Volume 23, Issue 101 (8-2015)                   J Adv Med Biomed Res 2015, 23(101): 45-54 | Back to browse issues page

XML Print


1- Dept .of Microbiology,Faculty of Science, Azad University, Shiraz, Iran
2- Infectious and Tropical Diseases Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran , Afsanehkk@yahoo.com
Abstract:   (154639 Views)

Background and Objective: Acinetobacter baumannii is considered as an important agent in nosocomial infections. The problem facing the tratment of these bacteria is increasing resistance to antimicrobial agents such as carbapenems. The main mechanism of resistance to carbapenems in these bacteria is the presence of  oxacillinases genes, which belong to class D betalactamases. The aim of this study was   molecular diagnosis of Acinetobacter baumannii and  antimicrobial resistance pattern of these bacteria to antibiotics including imipenem and meropenem. 

Materials and Methods: Genus and species of clinical isolates of Acinetobacter were identified via biochemical tests and PCR method respectively. Their susceptibily  to imipenem and meropenem  were determined by disk diffusion method.  In order to identify carbapenem resistant genes (oxacillinases), multiplex PCR was used.

Results: 76 of 72 (94.7%) Acinetobacter species, possessed bla oxa-51-like gene and were identified as  A.baumannii. Sixty one (84.7%) of isolates were resistant to imipenem and 70(97.2% ) were resistant to meropenem. Out of 76 isolates, 63 (87.5%) had an acquired bla oxa-23like carbapenemase, 7 (9.7%%) possessed bla oxa-24-like carbapenemase. None of the isolats contained either bla oxa-58 or bla oxa-143 carbapenemase.

Conclusions: It appears that cabapenem overutilization causes a selective pressure resulting in the emergence of antibiotic- resistant isolates. This study indicated that, the presence of bla oxa-23 genes was significantly associated with the occurrence of resistance to carbapenems. So, investigation of antibiotic resistance genes in A. baumannii is necessary to control further dissemination of these resistance genes.

Full-Text [PDF 213 kb]   (156247 Downloads)    
Type of Study: Clinical Trials |
Received: 2015/10/19 | Accepted: 2015/10/19 | Published: 2015/10/19

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.